Grantham, Mayo, Van Otterloo & Co (GMO)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Buy |
8,989
+6,467
| +256% | +$1.86M | 0.01% | 349 |
|
|
2025
Q1 | $777K | Sell |
2,522
-5,705
| -69% | -$1.76M | ﹤0.01% | 479 |
|
|
2024
Q4 | $2.9M | Buy |
8,227
+4,139
| +101% | +$1.46M | 0.01% | 346 |
|
|
2024
Q3 | $1.46M | Sell |
4,088
-24,634
| -86% | -$8.83M | ﹤0.01% | 397 |
|
|
2024
Q2 | $9.15M | Buy |
28,722
+21,486
| +297% | +$6.84M | 0.03% | 274 |
|
|
2024
Q1 | $1.66M | Buy |
+7,236
| New | +$1.66M | 0.01% | 371 |
|
|
2021
Q3 | – | Sell |
-2,068
| Closed | -$371K | – | 771 |
|
|
2021
Q2 | $371K | Sell |
2,068
-4,039
| -66% | -$725K | ﹤0.01% | 649 |
|
|
2021
Q1 | $1.02M | Sell |
6,107
-9,100
| -60% | -$1.52M | 0.01% | 591 |
|
|
2020
Q4 | $2.31M | Sell |
15,207
-24,700
| -62% | -$3.75M | 0.01% | 415 |
|
|
2020
Q3 | $4.03M | Buy |
39,907
+34,007
| +576% | +$3.44M | 0.03% | 269 |
|
|
2020
Q2 | $714K | Sell |
5,900
-2,400
| -29% | -$290K | 0.01% | 583 |
|
|
2020
Q1 | $787K | Buy |
+8,300
| New | +$787K | 0.01% | 529 |
|
|
2019
Q2 | – | Sell |
-5,700
| Closed | -$669K | – | 776 |
|
|
2019
Q1 | $669K | Sell |
5,700
-500
| -8% | -$58.7K | ﹤0.01% | 540 |
|
|
2018
Q4 | $675K | Hold |
6,200
| – | – | 0.01% | 390 |
|
|
2018
Q3 | $793K | Hold |
6,200
| – | – | 0.01% | 389 |
|
|
2018
Q2 | $702K | Buy |
6,200
+200
| +3% | +$22.6K | 0.01% | 409 |
|
|
2018
Q1 | $674K | Buy |
6,000
+3,600
| +150% | +$404K | ﹤0.01% | 412 |
|
|
2017
Q4 | $355K | Hold |
2,400
| – | – | ﹤0.01% | 480 |
|
|
2017
Q3 | $281K | Hold |
2,400
| – | – | ﹤0.01% | 467 |
|
|
2017
Q2 | $311K | Buy |
2,400
+900
| +60% | +$117K | ﹤0.01% | 439 |
|
|
2017
Q1 | $203K | Buy |
+1,500
| New | +$203K | ﹤0.01% | 522 |
|